Study of the Prevalence of Diabetes and Pre-diabetes in Réunion Island

ConditionDiabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCentre Hospitalier Universitaire de la Réunion

About this trial

In view of the new priority given to diabetes in Réunion and the implementation of an ambitious plan to combat the disease at regional level, which includes the identification and management of pre-diabetes, the need for up-to-date data on the extent of these 2 diseases (diabetes and pre-diabetes) has become essential.

These two diseases have known risk factors: age, overweight, obesity, high waist circumference, family history, hypertension, eating habits and physical activity, all of which form part of a risk score for developing diabetes: the Findrisk recommended by the Haute Autorité de Santé for identifying people at risk of diabetes. Given the specific population characteristics of Réunion compared with Finland, where this score has been validated, it would seem important to be able to measure these risk indicators in the population as a function of carbohydrate status in order to check that the proposed thresholds are appropriate for the population of Réunion.

Finally, cardiovascular risk has been described as early as the pre-diabetes stage. Given the young age of onset of diabetes in Réunion and the high proportion of diagnoses of diabetes made following the occurrence of a cardiovascular complication, the study of the prognosis of carbohydrate status on the occurrence of complications using the social security information system will be offered on a voluntary basis to study subjects (via a probabilistic social security link).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Have lived in Réunion island for at least one year

Be aged between 18 and 75

Affiliated to or benefiting from a social security scheme

Free, informed and signed consent

Disqualifiers

No main residence on the island or fixed address for at least one year on the island

Participation in experimental research

Pregnant women

Adults under guardianship or legal protection

Trial design

Design model

Single group

Treatments tested in this trial

  • Diabetes detection

    Diagnostic test

    Fasting glycemia on blood sample

Treatment groups

2,000 Participants
are divided into 1 treatment group
Group A: Detection of glycaemic anomaliesOther 1 intervention

Trial outcomes

Primary outcomes

1

Estimating the prevalence of glycaemic abnormalities (diabetes and pre-diabetes) in Réunion

Measurement of fasting blood glucose and blood glucose 2 hours after ingesting 75g of glucose (HGPO test) according to Haute Autorite de Sante (HAS) recommendations used in France for diagnosing diabetes and pre-diabetes in people with unknown diabetes

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier Universitaire de la Réunion

Lead sponsor

Agence Régionale de Santé de La Réunion

Collaborator